CASP3 and cancer: In recent years, studies demonstrated that survivin may also play a role in inhibiting the caspase-independent apoptosis in cancer cells [52,53], and that down-regulated survivin induced the translocation of apoptosis inducing factor (AIF) from the cytoplasm to the nucleus in cancer cells, while caspase 3 activity showed no change.